Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Erratum for Sekaggya-Wiltshire et al., "Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?"

Sekaggya-Wiltshire C, Chirehwa M, Musaazi J, von Braun A, Buzibye A, Muller D, Gutteck U, Motta I, Calcagno A, Fehr JS, Kambugu A, Castelnuovo B, Lamorde M, Denti P.

Antimicrob Agents Chemother. 2020 Mar 24;64(4). pii: e00315-20. doi: 10.1128/AAC.00315-20. Print 2020 Mar 24. No abstract available.

PMID:
32209563
2.

Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?

Sekaggya-Wiltshire C, Chirehwa M, Musaazi J, von Braun A, Buzibye A, Muller D, Gutteck U, Motta I, Calcagno A, Fehr JS, Kambugu A, Castelnuovo B, Lamorde M, Denti P.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02174-18. doi: 10.1128/AAC.02174-18. Print 2019 Jun. Erratum in: Antimicrob Agents Chemother. 2020 Mar 24;64(4):.

3.

High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men.

Braun DL, Hampel B, Martin E, Kouyos R, Kusejko K, Grube C, Flepp M, Stöckle M, Conen A, Béguelin C, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS; Swiss HIV Cohort Study.

Clin Infect Dis. 2019 Feb 1;68(4):561-568. doi: 10.1093/cid/ciy545.

PMID:
30107494
4.

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men.

Braun DL, Hampel B, Kouyos R, Nguyen H, Shah C, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule P, Nicca D, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS; Swiss HIV Cohort Study.

Clin Infect Dis. 2019 Feb 1;68(4):569-576. doi: 10.1093/cid/ciy547.

PMID:
30107485
5.

HIV pre-exposure prophylaxis (PrEP): Is it time to rethink HIV prevention in travelers?

Hampel B, Reinacher M, Fehr JS.

Travel Med Infect Dis. 2018 Sep - Oct;25:6-7. doi: 10.1016/j.tmaid.2018.06.008. Epub 2018 Jun 19. No abstract available.

PMID:
29929002
6.

Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.

Sekaggya-Wiltshire C, von Braun A, Lamorde M, Ledergerber B, Buzibye A, Henning L, Musaazi J, Gutteck U, Denti P, de Kock M, Jetter A, Byakika-Kibwika P, Eberhard N, Matovu J, Joloba M, Muller D, Manabe YC, Kamya MR, Corti N, Kambugu A, Castelnuovo B, Fehr JS.

Clin Infect Dis. 2018 Aug 16;67(5):708-716. doi: 10.1093/cid/ciy179.

7.

Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000-2016: a systematic review and meta-analysis.

Ghisla V, Scherrer AU, Nicca D, Braun DL, Fehr JS.

Infection. 2017 Jun;45(3):309-321. doi: 10.1007/s15010-016-0975-y. Epub 2016 Dec 22. Review.

PMID:
28005195
8.

Prescription of Postexposure Prophylaxis for HIV-1 in the Emergency Room: Correct Transmission Risk Assessment Remains Challenging.

Marzel A, Heinrich H, Schilliger L, Fehr JS, Günthard HF, Kouyos R, Rampini SK.

J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):359-366. doi: 10.1097/QAI.0000000000001265.

9.

Prosthetic valve endocarditis caused by Propionibacterium species successfully treated with coadministered rifampin: report of two cases.

Braun DL, Hasse BK, Stricker J, Fehr JS.

BMJ Case Rep. 2013 Jan 25;2013. pii: bcr2012007204. doi: 10.1136/bcr-2012-007204.

10.

Minority K65R variants and early failure of antiretroviral therapy in HIV-1-infected Eritrean immigrant.

Bansal V, Metzner KJ, Niederost B, Leemann C, Boni J, Gunthard HF, Fehr JS.

Emerg Infect Dis. 2011 Oct;17(10):1966-8. doi: 10.3201/eid1710.110592. No abstract available.

11.

Septicemia caused by tick-borne bacterial pathogen Candidatus Neoehrlichia mikurensis.

Fehr JS, Bloemberg GV, Ritter C, Hombach M, Lüscher TF, Weber R, Keller PM.

Emerg Infect Dis. 2010 Jul;16(7):1127-9. doi: 10.3201/eid1607.091907.

12.

Starting or changing therapy - a prospective study exploring antiretroviral decision-making.

Fehr JS, Nicca D, Sendi P, Wolf E, Wagels T, Kiss A, Bregenzer T, Vernazza P, Jäger H, Spirig R, Battegay M; Swiss HIV Cohort Study.

Infection. 2005 Aug;33(4):249-56.

PMID:
16091895

Supplemental Content

Support Center